Analyst Ratings for Cell Therapeutics (CTIC)
CTIC Rating Summary
CTIC Price Target Summary
- Highest: $4.00 (Roth Capital)
- Lowest: $3.00 (Rodman & Renshaw)
- Average: $3.33
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.33 (+187.4%)
Avg. $ Target:
$3.33 (+187.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/26/2012 | Roth Capital | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.54 | 1.16 | -24.68% | Details |
| 10/15/2012 | ThinkEquity | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.46 | 1.16 | -20.55% | Details |
| 2/21/2012 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
3.00 (N/A) |
1.35 | 1.16 | -14.07% | Details |
